Can acute myeloid leukemia M2A be cured?

In general, whether acute myeloid leukemia M2A can be cured depends on the risk level of the disease. Patients with low- to intermediate-risk M2A have a good chance of cure through standardized treatment, while those with high-risk M2A face greater challenges in achieving a cure. However, active treatment can still significantly extend survival. Detailed analysis is as follows:

If M2A leukemia is at a low or intermediate risk stage, patients usually respond well to chemotherapy. Through standard treatment procedures such as induction and consolidation chemotherapy, some patients can achieve complete remission. With subsequent maintenance therapy or hematopoietic stem cell transplantation, clinical cure becomes possible, and the long-term disease-free survival rate is relatively high.

For high-risk M2A leukemia, patients may have chromosomal abnormalities or gene mutations, resulting in lower sensitivity to conventional chemotherapy and reduced chances of cure. Nevertheless, optimizing chemotherapy regimens, combining targeted therapies, or undergoing hematopoietic stem cell transplantation at an early stage can effectively control disease progression, improve quality of life, and prolong survival.

In daily care, it is important to provide patients with a clean and hygienic environment to prevent infections. A balanced diet rich in high-quality proteins and fresh fruits and vegetables should be ensured to enhance the body's immune resistance.